Literature DB >> 24525277

Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations.

Yachiyo Kuwatsuka1, Yoshiko Atsuta2, Mary M Horowitz3, Jiro Inagaki4, Junya Kanda5, Koji Kato6, Katsuyoshi Koh7, Mei-Jie Zhang8, Mary Eapen3.   

Abstract

An earlier report identified higher risks of acute and chronic graft-versus-host disease (GVHD) in White children compared with the Japanese after HLA-matched sibling transplantations. The current analysis explored whether racial differences are associated with GVHD risks after unrelated umbilical cord blood transplantation. Included are patients of Japanese descent (n = 257) and Whites (n = 260; 168 of 260 received antithymocyte globulin [ATG]). Transplants were performed in the United States or Japan between 2000 and 2009; patients were aged 16 years or younger, had acute leukemia, were in complete remission, and received a myeloablative conditioning regimen. The median ages of the Japanese and Whites who received ATG were younger at 5 years compared with 8 years for Whites who did not receive ATG. In all groups most transplants were mismatched at 1 or 2 HLA loci. Multivariate analysis found no differences in risks of acute GVHD between the Japanese and Whites. However, chronic GVHD was higher in Whites who did not receive ATG compared with the Japanese (hazard ratio, 2.16; P < .001), and treatment-related mortality was higher in Whites who received ATG compared with the Japanese (relative risk, 1.81; P = .01). Nevertheless, there were no significant differences in overall survival between the 3 groups.
Copyright © 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GVHD; Umbilical cord blood transplantation

Mesh:

Substances:

Year:  2014        PMID: 24525277      PMCID: PMC4071962          DOI: 10.1016/j.bbmt.2014.01.020

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  29 in total

Review 1.  Pathophysiology and treatment of graft-versus-host disease.

Authors:  M E Flowers; E Kansu; K M Sullivan
Journal:  Hematol Oncol Clin North Am       Date:  1999-10       Impact factor: 3.722

2.  A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model.

Authors:  Xu Zhang; Fausto R Loberiza; John P Klein; Mei-Jie Zhang
Journal:  Comput Methods Programs Biomed       Date:  2007-09-11       Impact factor: 5.428

3.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

Authors:  Mary J Laughlin; Mary Eapen; Pablo Rubinstein; John E Wagner; Mei-Jei Zhang; Richard E Champlin; Cladd Stevens; Juliet N Barker; Robert P Gale; Hillard M Lazarus; David I Marks; Jon J van Rood; Andromachi Scaradavou; Mary M Horowitz
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

4.  Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.

Authors:  Hakumei Oh; Fausto R Loberiza; Mei-jie Zhang; Olle Ringdén; Hideki Akiyama; Takayoshi Asai; Shuichi Miyawaki; Shinichiro Okamoto; Mary M Horowitz; Joseph H Antin; Asad Bashey; Jennifer M Bird; Matthew H Carabasi; Joseph W Fay; Robert Peter Gale; Roger H Giller; John M Goldman; Gregory A Hale; Richard E Harris; Jean Henslee-Downey; Hans-Jochem Kolb; Mark R Litzow; Philip L McCarthy; Steven M Neudorf; Derek S Serna; Gerard Socié; Pierre Tiberghien; A John Barrett
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

5.  Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.

Authors:  Yoshiko Atsuta; Ritsuro Suzuki; Ayami Yoshimi; Hisashi Gondo; Junji Tanaka; Akira Hiraoka; Koji Kato; Ken Tabuchi; Masahiro Tsuchida; Yasuo Morishima; Makoto Mitamura; Keisei Kawa; Shunichi Kato; Tokiko Nagamura; Minoko Takanashi; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

6.  Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies.

Authors:  Satoshi Takahashi; Tohru Iseki; Jun Ooi; Akira Tomonari; Kashiya Takasugi; Yoko Shimohakamada; Toshiki Yamada; Kaoru Uchimaru; Arinobu Tojo; Naoki Shirafuji; Hideki Kodo; Kenzaburo Tani; Tsuneo Takahashi; Takuhiro Yamaguchi; Shigetaka Asano
Journal:  Blood       Date:  2004-07-27       Impact factor: 22.113

7.  Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

Authors:  Mary Eapen; Pablo Rubinstein; Mei-Jie Zhang; Cladd Stevens; Joanne Kurtzberg; Andromachi Scaradavou; Fausto R Loberiza; Richard E Champlin; John P Klein; Mary M Horowitz; John E Wagner
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

8.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

Review 9.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

10.  Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.

Authors:  Caroline A Lindemans; Robert Chiesa; Persis J Amrolia; Kanchan Rao; Olga Nikolajeva; Arianne de Wildt; Corinne E Gerhardt; Kimberly C Gilmour; Marc B Bierings; Paul Veys; Jaap J Boelens
Journal:  Blood       Date:  2013-11-01       Impact factor: 22.113

View more
  9 in total

1.  Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation.

Authors:  Junya Kanda; Katsutsugu Umeda; Koji Kato; Makoto Murata; Junichi Sugita; Souichi Adachi; Katsuyoshi Koh; Maiko Noguchi; Hiroaki Goto; Nao Yoshida; Maho Sato; Yuhki Koga; Tsukasa Hori; Yuko Cho; Atsushi Ogawa; Masami Inoue; Yoshiko Hashii; Yoshiko Atsuta; Takanori Teshima
Journal:  Bone Marrow Transplant       Date:  2020-03-11       Impact factor: 5.483

2.  Efficiency of allogeneic hematopoietic SCT from HLA fully-matched non-sibling relatives: a new prospect of exploiting extended family search.

Authors:  A A Hamidieh; M Ostadali Dehaghi; P Paragomi; S Navaei; A Jalali; G Ghazizadeh Eslami; M Behfar; A Ghavamzadeh
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

Review 3.  Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.

Authors:  Makoto Murata
Journal:  Int J Hematol       Date:  2015-04-12       Impact factor: 2.490

4.  HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation.

Authors:  T Yabe; F Azuma; K Kashiwase; K Matsumoto; T Orihara; H Yabe; S Kato; K Kato; S Kai; T Mori; S Morishima; M Satake; M Takanashi; K Nakajima; Y Morishima
Journal:  Leukemia       Date:  2017-06-27       Impact factor: 11.528

5.  Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation.

Authors:  Nobuhiro Hiramoto; Hirohito Yamazaki; Yukinori Nakamura; Naoyuki Uchida; Makoto Murata; Tadakazu Kondo; Satoshi Yoshioka; Tetsuya Eto; Akinori Nishikawa; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Yasushi Onishi; Ritsuro Suzuki; Takehiko Mori
Journal:  Ann Hematol       Date:  2021-09-21       Impact factor: 3.673

Review 6.  Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology.

Authors:  M J Rioth; J Warner; B N Savani; M Jagasia
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

7.  Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML.

Authors:  C-C Zheng; X-Y Zhu; B-L Tang; X-H Zhang; L Zhang; L-Q Geng; H-L Liu; Z-M Sun
Journal:  Bone Marrow Transplant       Date:  2016-07-04       Impact factor: 5.483

8.  Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations.

Authors:  Junya Kanda; Ruta Brazauskas; Zhen-Huan Hu; Yachiyo Kuwatsuka; Koji Nagafuji; Heiwa Kanamori; Yoshinobu Kanda; Koichi Miyamura; Makoto Murata; Takahiro Fukuda; Hisashi Sakamaki; Fumihiko Kimura; Sachiko Seo; Mahmoud Aljurf; Ayami Yoshimi; Giuseppe Milone; William A Wood; Celalettin Ustun; Shahrukh Hashimi; Marcelo Pasquini; Carmem Bonfim; Jignesh Dalal; Theresa Hahn; Yoshiko Atsuta; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2016-01-04       Impact factor: 5.742

9.  Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial.

Authors:  Kenichi Yamahara; Akiko Hamada; Toshihiro Soma; Rika Okamoto; Masaya Okada; Satoshi Yoshihara; Kyoko Yoshihara; Kazuhiro Ikegame; Hiroya Tamaki; Katsuji Kaida; Takayuki Inoue; Yuko Ohsugi; Hiroki Nishikawa; Hiroshi Hayashi; Yoichi M Ito; Hiroaki Iijima; Shunsuke Ohnishi; Daigo Hashimoto; Toshiyuki Isoe; Takanori Teshima; Hiroyasu Ogawa; Norihiro Sato; Yoshihiro Fujimori
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.